REVB FY 2022 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$40,008

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-9643.37

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$301,116

Balance Sheet

Total Assets

$6M

Total Liabilities

$4M

Stockholders' Equity

$1M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$40,008	-$69,166	+42.2%
Operating Income	-$11M	-$12M	+9.1%
Net Income	-$11M	-$12M	+9.7%